Cherry Hill, NJ, May 27, 2009 – Nuvilex, Inc. (OTCBB: NVLX), an emerging healthcare consumer products company, announced today that InfinitinkTM, the world’s first permanent tattoo ink designed to be both safe and more easily removed, is the subject of a June 1st article in Time Magazine. The story, “Too Fickle for a Tattoo?” updates readers on Infinitink, a product developed to address tattoo regret and broaden the audience for this already popular art form. 

“Artists report that new customers requesting Infinitink are most often part of the ‘fence-sitter’ group, those who have considered getting a tattoo, but have not gotten one because of concerns about permanence,” said Martin Schmieg, Chairman and CEO of Nuvilex, Inc. “According to market surveys, this group represents 25% of the over 18-year-old U.S. population. Therefore, we expect strong demand for our solution.”

Infinitink was selected as one of Time Magazine’s ‘Products of the Year’ in its November 12, 2007 issue. Since then, Infinitink has undergone further testing and development. Infinitink is now available throughout the United States. To learn more about Infinitink, or to locate an artist, log onto www.Infinitink.com.

About Nuvilex, Inc.
Nuvilex, formerly eFoodSafety.com, is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercializing healthcare products that address the health needs of consumers worldwide. In March 2009, Nuvilex merged with Freedom2 Holdings, Inc., a diversified skin products technology company serving the fast-growing body art, aesthetic, cosmetic and skin therapy markets. More information is available at: http://www.nuvilex.com or www.freedom2inc.com.

Safe Harbor Statement

Statements contained in this presentation that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Forward-looking statements are sometimes identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and involve a number of risks and uncertainties that could cause the Company's actual results to differ materially from projected results. All parties are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, the planned share exchange with Freedom2 Holdings, Inc., our ability to secure additional financing, and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

Investor Relations Contacts:

Blair Barnes
Senior Vice President and Chief Financial Officer
Nuvilex, Inc.
Ph: 856-433-6088
Email: bbarnes@nuvilex.com

Stephanie Carrington/Amy Glynn
The Ruth Group
Ph: 646-536-7017/7023
Email: scarrington@theruthgroup.com
Email: aglynn@theruthgroup.com

Press Contact:

Pat Arcand
Arcand & Madison
Ph: 617-576-7777
Email: pat@am-pr.com